Join
Live feed
·
INSIDERFilingvia Quantisnow
Poseida Therapeutics Inc. logo

SEC Form 4: Ingalls Kerry D. bought $11,940 worth of shares (3,000 units at $3.98), increasing direct ownership by 6% to 55,000 units

ByQuantisnow·Wall Street's wire, on your screen.
PSTX· Poseida Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PSTX (Poseida Therapeutics Inc.) and more on Quantisnow.